PLEUROPULMONARY INVOLVEMENT DURING BROMOCRIPTINE TREATMENT

被引：26

作者：

KINNUNEN, E ^{[1
]}

VILJANEN, A ^{[1
]}

机构：

[1] MELTOLA HOSP,DEPT PULM MED,HELSINKI,FINLAND

来源：

关键词：

D O I：

10.1378/chest.94.5.1034

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

页码：1034 / 1036

页数：3

共 12 条

[1] BROMOCRIPTINE IN PARKINSONISM
CALNE, DB
TEYCHENNE, PF
CLAVERIA, LE
EASTMAN, R
GREENACRE, JK
PETRIE, A
[J]. BMJ-BRITISH MEDICAL JOURNAL, 1974, 4 (5942): : 442 - 444
[2] EFFECT OF ERGOT DRUGS ON CENTRAL CATECHOLAMINE NEURONS - EVIDENCE FOR A STIMULATION OF CENTRAL DOPAMINE NEURONS
CORRODI, H
FUXE, K
HOKFELT, T
LIDBRINK, P
UNGERSTEDT, U
[J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1973, 25 (05) : 409 - 412
[3] PLEURAL EFFUSION AND FIBROSIS DURING TREATMENT WITH METHYSERGIDE
HINDLE, W
POSNER, E
SWEETNAM, MT
TAN, RSH
[J]. BRITISH MEDICAL JOURNAL, 1970, 1 (5696) : 605 - &
[4] RECENT ADVANCES IN THE TREATMENT OF PARKINSONS-DISEASE - THE ROLE OF BROMOCRIPTINE
LEWITT, PA
CALNE, DB
[J]. JOURNAL OF NEURAL TRANSMISSION, 1981, 51 (1-2) : 175 - 184
[5] LYMPHOCYTE-T AND LYMPHOCYTE-B IN PLEURAL EFFUSIONS
PETTERSSON, T
KLOCKARS, M
HELLSTROM, PE
RISKA, H
WANGEL, A
[J]. CHEST, 1978, 73 (01) : 49 - 51
[6] COMBINED BROMOCRIPTINE-LEVODOPA THERAPY EARLY IN PARKINSONS-DISEASE
RINNE, UK
[J]. NEUROLOGY, 1985, 35 (08) : 1196 - 1198
[7] RINNE UK, 1981, LANCET, V1, P44
[8] SAHN SA, 1985, CLIN CHEST MED, V6, P83
[9] TORNLING G, 1986, EUR J RESPIR DIS, V68, P35
[10] VERGERET J, 1984, SEM HOP PARIS, V60, P741